Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with α 1- plus β 3-adrenoreceptor antagonists

Jon E. Sprague, Robert E. Brutcher, Edward M. Mills, David Caden, Daniel Rusyniak

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

1. Studies were designed to examine the effects of α 1, (a 1AR)- plus β 3-adrenoreceptor (β 3AR) antagonists on 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced hyperthermia and measures of rhabdomyolysis (creatine kinase (CK)) and renal function (blood urea nitrogen (BUN) and serum creatinine (sCr)) in male Sprague-Dawley rats. 2. MDMA (40 mg kg -1, s.c.) induced a rapid and robust increase in rectal temperature, which was significantly attenuated by pretreatment with the α 1AR antagonist prazosin (100 μg kg -1, i.p.) plus the β 3AR antagonist SR59230A (5 mg kg -1, i.p.). 3. CK levels significantly increased (peaking at 4 h) after MDMA treatment and were blocked by the combination of prazosin plus SR59230A. 4. At 4 h after MDMA treatment, BUN and sCr levels were also significantly increased and could be prevented by this combination of α 1AR- plus β 3AR-antagonists. 5. The results from this study suggest that α 1AR and β 3AR play a critical role in the etiology of MDMA-mediated hyperthermia and subsequent rhabdomyolysis.

Original languageEnglish
Pages (from-to)667-670
Number of pages4
JournalBritish Journal of Pharmacology
Volume142
Issue number4
DOIs
StatePublished - Jun 2004

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Rhabdomyolysis
Prazosin
Blood Urea Nitrogen
Creatine Kinase
Creatinine
Induced Hyperthermia
Serum
Sprague Dawley Rats
Fever
Kidney
Temperature
Therapeutics

Keywords

  • 3,4-Methylenedioxymethamphetamine (MDMA)
  • Creatine kinase
  • Rhabdomyolysis
  • Thermogenesis
  • UCP-3

ASJC Scopus subject areas

  • Pharmacology

Cite this

Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with α 1- plus β 3-adrenoreceptor antagonists. / Sprague, Jon E.; Brutcher, Robert E.; Mills, Edward M.; Caden, David; Rusyniak, Daniel.

In: British Journal of Pharmacology, Vol. 142, No. 4, 06.2004, p. 667-670.

Research output: Contribution to journalArticle

@article{5e6cfb62679246f6910aacadb0a8b7c0,
title = "Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with α 1- plus β 3-adrenoreceptor antagonists",
abstract = "1. Studies were designed to examine the effects of α 1, (a 1AR)- plus β 3-adrenoreceptor (β 3AR) antagonists on 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced hyperthermia and measures of rhabdomyolysis (creatine kinase (CK)) and renal function (blood urea nitrogen (BUN) and serum creatinine (sCr)) in male Sprague-Dawley rats. 2. MDMA (40 mg kg -1, s.c.) induced a rapid and robust increase in rectal temperature, which was significantly attenuated by pretreatment with the α 1AR antagonist prazosin (100 μg kg -1, i.p.) plus the β 3AR antagonist SR59230A (5 mg kg -1, i.p.). 3. CK levels significantly increased (peaking at 4 h) after MDMA treatment and were blocked by the combination of prazosin plus SR59230A. 4. At 4 h after MDMA treatment, BUN and sCr levels were also significantly increased and could be prevented by this combination of α 1AR- plus β 3AR-antagonists. 5. The results from this study suggest that α 1AR and β 3AR play a critical role in the etiology of MDMA-mediated hyperthermia and subsequent rhabdomyolysis.",
keywords = "3,4-Methylenedioxymethamphetamine (MDMA), Creatine kinase, Rhabdomyolysis, Thermogenesis, UCP-3",
author = "Sprague, {Jon E.} and Brutcher, {Robert E.} and Mills, {Edward M.} and David Caden and Daniel Rusyniak",
year = "2004",
month = "6",
doi = "10.1038/sj.bjp.0705823",
language = "English",
volume = "142",
pages = "667--670",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with α 1- plus β 3-adrenoreceptor antagonists

AU - Sprague, Jon E.

AU - Brutcher, Robert E.

AU - Mills, Edward M.

AU - Caden, David

AU - Rusyniak, Daniel

PY - 2004/6

Y1 - 2004/6

N2 - 1. Studies were designed to examine the effects of α 1, (a 1AR)- plus β 3-adrenoreceptor (β 3AR) antagonists on 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced hyperthermia and measures of rhabdomyolysis (creatine kinase (CK)) and renal function (blood urea nitrogen (BUN) and serum creatinine (sCr)) in male Sprague-Dawley rats. 2. MDMA (40 mg kg -1, s.c.) induced a rapid and robust increase in rectal temperature, which was significantly attenuated by pretreatment with the α 1AR antagonist prazosin (100 μg kg -1, i.p.) plus the β 3AR antagonist SR59230A (5 mg kg -1, i.p.). 3. CK levels significantly increased (peaking at 4 h) after MDMA treatment and were blocked by the combination of prazosin plus SR59230A. 4. At 4 h after MDMA treatment, BUN and sCr levels were also significantly increased and could be prevented by this combination of α 1AR- plus β 3AR-antagonists. 5. The results from this study suggest that α 1AR and β 3AR play a critical role in the etiology of MDMA-mediated hyperthermia and subsequent rhabdomyolysis.

AB - 1. Studies were designed to examine the effects of α 1, (a 1AR)- plus β 3-adrenoreceptor (β 3AR) antagonists on 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced hyperthermia and measures of rhabdomyolysis (creatine kinase (CK)) and renal function (blood urea nitrogen (BUN) and serum creatinine (sCr)) in male Sprague-Dawley rats. 2. MDMA (40 mg kg -1, s.c.) induced a rapid and robust increase in rectal temperature, which was significantly attenuated by pretreatment with the α 1AR antagonist prazosin (100 μg kg -1, i.p.) plus the β 3AR antagonist SR59230A (5 mg kg -1, i.p.). 3. CK levels significantly increased (peaking at 4 h) after MDMA treatment and were blocked by the combination of prazosin plus SR59230A. 4. At 4 h after MDMA treatment, BUN and sCr levels were also significantly increased and could be prevented by this combination of α 1AR- plus β 3AR-antagonists. 5. The results from this study suggest that α 1AR and β 3AR play a critical role in the etiology of MDMA-mediated hyperthermia and subsequent rhabdomyolysis.

KW - 3,4-Methylenedioxymethamphetamine (MDMA)

KW - Creatine kinase

KW - Rhabdomyolysis

KW - Thermogenesis

KW - UCP-3

UR - http://www.scopus.com/inward/record.url?scp=3242779222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242779222&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0705823

DO - 10.1038/sj.bjp.0705823

M3 - Article

VL - 142

SP - 667

EP - 670

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 4

ER -